Palliative resection of advanced primary hepatocellular carcinoma
- VernacularTitle:姑息性切除治疗中晚期肝癌
- Author:
Yunfu LI
;
Guanrui YE
;
Meirong LI
;
Yanjin HUANG
;
Sibo PAN
- Publication Type:Journal Article
- From:
Chinese Journal of General Surgery
2001;10(2):120-122
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect of palliative resection of advanced primary hepatocellular carcinoma (PHCC). Methods 98 patients with advanced PHCC were divided randomly into two groups in our hospital from March 1996 to Jan. 2000:(1) Therapy group (49 cases), dealt with palliative resection of liver cancer and implanted with a drug delivery system (DDS). (2) Control group (49 cases), only implanted with DDS. Results In therapy group and control group, The decline rate of AFP was 60.0% and 31.7% respectively (P<0.05); and the survival rates of 0.5, 1, 3 years after operation were 85.7% (42/49), 60.5%(23/38), 45.4%(10/22) and 67.3%(33/49), 32.5%(13/40), 10%(2/20) (P<0.05). Conclusions Palliative resection of liver cancer can improve survival duration and life quality of patients with advanced HCC.
